Advances in immunotyping of colorectal cancer

Immunotherapy has transformed treatment for various types of malignancy. However, the benefit of immunotherapy is limited to a minority of patients with mismatch-repair-deficient (dMMR) and microsatellite instability-high (MSI-H) (dMMR-MSI-H) colorectal cancer (CRC). Understanding the complexity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yinhang, Zhuang, Jing, Qu, Zhanbo, Yang, Xi, Han, Shuwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590894/
https://www.ncbi.nlm.nih.gov/pubmed/37876934
http://dx.doi.org/10.3389/fimmu.2023.1259461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590894/
https://www.ncbi.nlm.nih.gov/pubmed/37876934
http://dx.doi.org/10.3389/fimmu.2023.1259461

Ejemplares similares